London: digital health tools and technologies such as artificial intelligence (AI) and machine learning (ML) is expected to be further integrated into the healthcare industry due to the impact of the COVID-19 pandemic. Against this backdrop, the market for AI platforms for the entire healthcare industry will grow from $1.5 billion in 2019 to $4.3 billion in 2024, according to forecasts. global data.
Several healthcare companies are already implementing high-tech solutions into existing healthcare systems. French biotech company Genomic Visionwhich specializes in the development and commercialization of diagnostic solutions for genetic diseases and cancers, has recently launched FiberSmarta new technology that allows the visualization and analysis of dna strands in high resolution.
Genomic Vision claims that FiberSmart has the potential to improve the accuracy and efficiency of the diagnosis and treatment of genetic diseases, leading to better patient outcomes and lower healthcare costs.
Kamilla Kan, Medical Analyst at GlobalData, commented: “The integration of digital health tools and technologies like AI and ML to analyze vast amounts of data and identify patterns and insights is transforming the healthcare industry and paving the way for better care. more personalized and efficient medical care. . Additionally, AI is being used to improve the accuracy and efficiency of diagnoses, identify new treatments and therapies, and even predict and prevent disease outbreaks.
“The growing market for AI platforms in healthcare reflects the increasing demand for innovative solutions that can improve patient outcomes and reduce costs. As companies like Genomic Vision continue to develop and implement high-tech solutions, GlobalData expects even more significant advances in the field of healthcare in the coming years.”
